Cycle for Survival is the movement to beat rare cancers. Our high-energy indoor team cycling events provide a tangible way for you to fight back—100% of all money raised directly funds lifesaving rare cancer research. Equinox is the founding partner of Cycle for Survival, and is proud to continue to contribute to the event’s success.
An estimated 1,685,210 new cancer cases will be diagnosed in 2016.
About 50 percent of people with cancer have a rare cancer. Rare cancers include brain, pancreatic, ovarian, stomach, all types of pediatric cancers, and many others. Even though they account for about half of all cancer diagnoses when combined, research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality. MSK’s close collaboration between doctors and researchers is a unique strength: new drugs and therapies developed in the lab can be moved quickly to patients’ bedsides.
100% of every donation to Cycle for Survival is directly allocated to research at Memorial Sloan Kettering Cancer Center within six months of the events. The donations go to pioneering research and clinical trials, and have already led to new and better treatments for cancer patients worldwide. Memorial Sloan Kettering researchers collaborate with institutions around the world, and have led the way in developing new ways to diagnose and treat cancer. If you want to fight back against cancer, join us!
Thanks to the tremendous efforts of our participants, donors, and supporters, Cycle for Survival has raised $105 million for rare cancer research, and funded 100+ clinical trials and research studies. Please consider helping with a donation.
The direct funding has drastically reduced the time it takes for treatments to reach patients—in some cases cutting the span from years to months. Doctors and researchers who have received Cycle for Survival funding credit these resources for making groundbreaking discoveries possible, advancing vital research where—typically—little to no funding exists.
Learn more about Equinox
Learn more about Memorial Sloan Kettering Cancer Center